A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
Status:
Terminated
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the effects of total volume and total dose on the
safety and intraocular pressure-lowering efficacy of Anecortave Acetate Suspension (3 mg and
48 mg) in 0.5 mL and 0.8 mL volumes when administered by anterior juxtascleral depot (AJD)
for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma
or ocular hypertension.